Doctor profile · Federal record
Dr. Dickran Kazandjian, M.D.
Hematology & Oncology Physician (CMS: Medical Oncology) · Internal Medicine Physician · Miami, FL
- NPI 1114096567
- Accepts Medicare
- MIPS 94.3 / 100 · 2023
- 23 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1120 Nw 14Th St Rm 828
Miami, FL 331362107
(305) 243-5001
Credentials & registration
- NPI registered
- November 2006 — 20 yrs on file
- Profile last updated
- June 28, 2022
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Florida #ME148320 · Virginia #0101236863
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1114096567. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
407
Distinct HCPCS
3
Medicare allowed
$60,457
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 363 | 109 | $153 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 22 | 22 | $196 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 22 | 11 | $33 |
In context: peer comparison
Among 53 peers in Miami Hematology & Oncology Physician, average services per provider: 140. This provider delivers 2.9× the peer median.Open Payments
Industry payments received
All-time total
$13,457
Transactions
35
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Karyopharm Therapeutics INC. | 9 | $10,972.41 | |
| Genzyme Corporation | 9 | $1,462.27 | |
| Janssen Biotech, INC. | 13 | $627.38 | |
| Adaptive Biotechnologies Corporation | 3 | $307.39 | |
| Genentech USA, INC. | 1 | $87.82 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
400
Patients
87
Total drug cost
$3,945,478
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Lenalidomide | Generic | 139 | 28 | $1,929,914 |
| Revlimid (Lenalidomide) | Brand | 108 | 25 | $1,963,182 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 57 | 18 | $2,722 |
| Eliquis (Apixaban) | Brand | 51 | 16 | $49,236 |
| Acyclovir | Generic | 22 | 0 | $271 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 12 | 0 | $76 |
| Trazodone Hcl | Generic | 11 | 0 | $77 |
Frequently asked questions
What is Dr. Dickran Kazandjian's medical specialty?
Dr. Dickran Kazandjian practices Hematology & Oncology Physician in Miami, FL.
Where does Dr. Dickran Kazandjian practice?
Dr. Dickran Kazandjian practices at 1120 Nw 14Th St Rm 828, Miami, FL 331362107. Office phone: 3052435001.
What is Dr. Dickran Kazandjian's NPI?
Dr. Dickran Kazandjian's National Provider Identifier (NPI) is 1114096567, issued by NPPES.
Does Dr. Dickran Kazandjian accept Medicare assignment?
Yes. Dr. Dickran Kazandjian accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dickran Kazandjian commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); New patient office or other outpatient visit (HCPCS 99205); Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS G2212). Source: CMS Medicare Physician & Other Practitioners file.